RE:RE:If you cut 2016 ebitda to $560 mln......I think people are putting too much blame on the shorts and losing sight of whats actually going on in an effort to not admit to themselves they may have made a mistake. Too much scapegoating going on here. With the news today that a major US player is dropping 2 of Concordias drugs on top of recent news that the Nhs also recommended doctors stop prescribing a Concordia drug and Fda uncertainty regarding Concordias biggest drug people can stop blaming shorts. These are real concerns that the market has real reason to be worried over. Anything that chips away at revenue in a company with as much debt as Concordia is rightfully going to set off alarm bells in the markets eyes.
Beckysboss wrote: CookieMonster wrote: The interest charges on the debt is roughly $220 mln. Capex and taxes are minimal.
The shorts are running a campaign of FUD (fear, uncertainty , doubt) just before earnings because they know this likely their last gasp. Cohodes probably had the Business Insider article set up to go and decided the market looked vulnerable , talk about insiders knowing earnings are going to be bad, blah, blah, blah, release the article and get the retail shorters to work the game.
Typical short game plan. Just like longs they get over confident, sit on a position to long, get boisterous with momentum on their side. Cohodes will probably be covering his short as retail shorts get cocky and get taken for a ride.